Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Regulation of vascular inflammation and remodeling by ETS factors.

Oettgen P.

Circ Res. 2006 Nov 24;99(11):1159-66. Review.

2.

The Ets family contains transcriptional activators and repressors involved in angiogenesis.

Lelièvre E, Lionneton F, Soncin F, Vandenbunder B.

Int J Biochem Cell Biol. 2001 Apr;33(4):391-407. Review.

PMID:
11312108
3.

Molecular biology of the Ets family of transcription factors.

Oikawa T, Yamada T.

Gene. 2003 Jan 16;303:11-34. Review.

PMID:
12559563
4.

The transcription factor Ets-1 in breast cancer.

Lincoln DW 2nd, Bove K.

Front Biosci. 2005 Jan 1;10:506-11. Print 2005 Jan 1. Review.

PMID:
15574387
5.
6.

Critical role for the Ets transcription factor ELF-1 in the development of tumor angiogenesis.

Huang X, Brown C, Ni W, Maynard E, Rigby AC, Oettgen P.

Blood. 2006 Apr 15;107(8):3153-60. Epub 2005 Dec 13.

7.

Promoter cloning and characterization of the anti-vascular proliferation gene, R-ras: role of Ets- and Sp-binding motifs.

Xu L, Komatsu M.

J Biol Chem. 2009 Jan 30;284(5):2706-18. doi: 10.1074/jbc.M808184200. Epub 2008 Nov 14.

8.

ETS transcription factors in endocrine systems.

Gutierrez-Hartmann A, Duval DL, Bradford AP.

Trends Endocrinol Metab. 2007 May-Jun;18(4):150-8. Epub 2007 Mar 26. Review.

PMID:
17387021
9.

Regulation of angiogenesis by ETS transcription factors.

Randi AM, Sperone A, Dryden NH, Birdsey GM.

Biochem Soc Trans. 2009 Dec;37(Pt 6):1248-53. doi: 10.1042/BST0371248. Review.

PMID:
19909256
10.

Ets target genes: past, present and future.

Sementchenko VI, Watson DK.

Oncogene. 2000 Dec 18;19(55):6533-48. Review.

11.

ETS transcription factors and their emerging roles in human cancer.

Seth A, Watson DK.

Eur J Cancer. 2005 Nov;41(16):2462-78. Epub 2005 Oct 6. Review.

PMID:
16213704
12.

The biology of the Ets1 proto-oncogene.

Dittmer J.

Mol Cancer. 2003 Aug 20;2:29. Review.

14.

ETS transcription factors and regulation of immunity.

Gallant S, Gilkeson G.

Arch Immunol Ther Exp (Warsz). 2006 May-Jun;54(3):149-63. Epub 2006 May 2. Review.

PMID:
16652219
15.

Lymphatics and vascular channels; the differences behind similarity.

Jones PF.

J Pathol. 2003 Aug;200(5):551-2.

PMID:
12898589
16.
17.

Ets regulates peroxiredoxin1 and 5 expressions through their interaction with the high-mobility group protein B1.

Shiota M, Izumi H, Miyamoto N, Onitsuka T, Kashiwagi E, Kidani A, Hirano G, Takahashi M, Ono M, Kuwano M, Naito S, Sasaguri Y, Kohno K.

Cancer Sci. 2008 Oct;99(10):1950-9. doi: 10.1111/j.1349-7006.2008.00912.x.

18.

The epithelial-specific Ets factors occupy a unique position in defining epithelial proliferation, differentiation and carcinogenesis.

Feldman RJ, Sementchenko VI, Watson DK.

Anticancer Res. 2003 May-Jun;23(3A):2125-31. Review.

PMID:
12894586
19.

Proteomic analysis of a PDEF Ets transcription factor-interacting protein complex.

Cho JY, Lee M, Ahn JM, Park ES, Cho JH, Lee SJ, Kim BG, Heo SH, Park HJ, Zerbini LF, Hwang D, Libermann TA.

J Proteome Res. 2009 Mar;8(3):1327-37. doi: 10.1021/pr800683b.

PMID:
19203193
20.

Multiple roles of the epithelium-specific ETS transcription factor, ESE-1, in development and disease.

Oliver JR, Kushwah R, Hu J.

Lab Invest. 2012 Mar;92(3):320-30. doi: 10.1038/labinvest.2011.186. Epub 2011 Dec 12. Review.

Supplemental Content

Support Center